News & Updates

In a cohort of veterans with COVID-19, former smokers are at higher risk of 30-day mortality compared with current smokers and nonsmokers, as reported in a study.

Adding interferon beta-1a to remdesivir did not hasten time to recovery among adults hospitalized with COVID-19, according to results of the phase III ACTT*-3 trial.

Diabetes does not appear to predispose SARS-CoV-2–infected patients to long-term post-COVID-19 symptoms, a study reports.

A large prospective, observational study has suggested that while individuals with a history of high-risk allergy may have an increased risk of allergic reactions following receipt of a messenger RNA (mRNA) COVID-19 vaccine, they are still able to receive both vaccine doses.

Compared with nasopharyngeal swabs (NPS), saliva samples provide higher diagnostic yield for detecting positivity to the coronavirus disease 2019 (COVID-19), a recent study has found.

A short-term treatment regimen based on high-dose gatifloxacin appears to be effective against multidrug- or rifampicin-resistant tuberculosis (TB) but at the cost of increased severe adverse drug reactions, as shown in a study.